SCHEMBL13927979

SCHEMBL13927979

Nc1ncnc2nc(-c3ccc(O)c(O)c3)c(-c3ccc(O)cc3)nc12

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 11/20 0.89
ADK P55263 2/20 0.51
PIK3CD O00329 1/20 0.43
PIK3C2B O00750 1/20 0.43
PDXK O00764 1/20 0.43
GAK O14976 1/20 0.43
MAP3K7 O43318 1/20 0.43
RIPK2 O43353 1/20 0.43
PIP5K1C O60331 1/20 0.43
STK16 O75716 1/20 0.43
PIK3C2G O75747 1/20 0.43
PRKD3 O94806 1/20 0.43
OXSR1 O95747 1/20 0.43
LATS1 O95835 1/20 0.43
ABL1 P00519 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
LCK P06239 1/20 0.43
BRAF P15056 1/20 0.43
CSNK2A2 P19784 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3533560 0.94 PIK3CG (1.00) PIK3CGADKPIK3CDPIK3C2BPDXK
Hydrochloric Acid SCHEMBL3536157 0.93 PIK3CG (0.97) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL3532692 0.90 PIK3CG (1.00) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL13043249 0.87 PIK3CG (0.85) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL3732209 0.86 PIK3CG (0.82) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL13019024 0.83 PIK3CG (0.86) PIK3CGADKPIK3CDABL1EGFR
Sulfuric Acid SCHEMBL3536726 0.83 PIK3CG (0.86) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL3536162 0.82 PIK3CG (0.75) PIK3CGADKPIK3CDPIK3C2BPDXK
SCHEMBL3745440 0.79 PIK3CG (0.70) PIK3CGADKPIK3CDABL1EGFR
SCHEMBL3745443 0.79 PIK3CG (0.70) PIK3CGADKPIK3CDPIK3C2BPDXK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039683-A2 Vasculostatic agents and methods of use thereof Targegen, Inc. (US) 2009-03-25 EP disclosed